标题
In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy
作者
关键词
-
出版物
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 71, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-07-08
DOI
10.1007/s00005-023-00683-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
- (2023) Ting Yan et al. Experimental Hematology & Oncology
- Practical issues in CAR T-cell therapy
- (2023) Ja Min Byun Blood Research
- The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
- (2022) Esteve Trias et al. BONE MARROW TRANSPLANTATION
- Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
- (2022) Hidefumi Mukai et al. Drug Metabolism and Pharmacokinetics
- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Engineered T Cells: CAR T Cell Therapy and Beyond
- (2022) P. Connor Johnson et al. Current Oncology Reports
- PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
- (2022) Malgorzata Bajor et al. Journal for ImmunoTherapy of Cancer
- In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
- (2022) Tianqing Xin et al. Frontiers in Oncology
- CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
- (2022) Kevin Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
- (2022) Manasi P. Jogalekar et al. Frontiers in Immunology
- Next generations of CAR-T cells - new therapeutic opportunities in hematology?
- (2022) Jaromir Tomasik et al. Frontiers in Immunology
- Automated, scaled, transposon-based production of CAR T cells
- (2022) Dominik Lock et al. Journal for ImmunoTherapy of Cancer
- Co-Stimulatory Receptor Signaling in CAR-T Cells
- (2022) Mackenzie M. Honikel et al. Biomolecules
- Advancements in Cancer Immunotherapies
- (2022) Ruchi Roy et al. Vaccines
- Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen
- (2021) Seigo Kimura et al. JOURNAL OF CONTROLLED RELEASE
- Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
- (2021) Shuai Liu et al. NATURE MATERIALS
- Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
- (2021) Lara Milane et al. Drug Delivery and Translational Research
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
- (2021) Mikyung Kang et al. ADVANCED MATERIALS
- Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
- (2021) István Tombácz et al. MOLECULAR THERAPY
- Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
- (2021) Ehsan Moghanloo et al. Translational Oncology
- AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia
- (2021) Waqas Nawaz et al. Blood Cancer Journal
- Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
- (2021) Justin T Huckaby et al. Journal for ImmunoTherapy of Cancer
- Chemistry of Lipid Nanoparticles for RNA Delivery
- (2021) Yulia Eygeris et al. ACCOUNTS OF CHEMICAL RESEARCH
- On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
- (2021) Sean A. Dilliard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)
- (2021) Ester Álvarez-Benedicto et al. Biomaterials Science
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Third-Generation CAR T Cells Targeting CD19 Are Associated with an Excellent Safety Profile and Might Improve Persistence of CAR T Cells in Treated Patients
- (2020) Maria-Luisa Schubert et al. BLOOD
- The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution
- (2020) Takashi Nakamura et al. MOLECULAR PHARMACEUTICS
- Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs
- (2020) Qing Li et al. ACS Chemical Biology
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold
- (2020) Kento Fujiwara et al. Cells
- CAR-T design: Elements and their synergistic function
- (2020) Jayapriya Jayaraman et al. EBioMedicine
- CD19-Specific CAR-T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor is Effective in Patients with PD-L1 Positive B-Cell Lymphoma
- (2020) Hui Liu et al. CLINICAL CANCER RESEARCH
- A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
- (2020) Sang Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
- (2019) Dwivedi Alka et al. Frontiers in Immunology
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer
- (2019) Mahmoud Hassani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Managing the toxicities of CAR T‐cell therapy
- (2019) Sattva S. Neelapu HEMATOLOGICAL ONCOLOGY
- Gene editing for immune cell therapies
- (2019) Stefanie R. Bailey et al. NATURE BIOTECHNOLOGY
- Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines
- (2019) Roshan Goswami et al. ACS Infectious Diseases
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- In vivo generated human CAR T cells eradicate tumor cells
- (2019) Shiwani Agarwal et al. OncoImmunology
- Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
- (2019) Katsiaryna Marhelava et al. Cancers
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Optimized DNA electroporation for primary human T cell engineering
- (2018) Zhang Zhang et al. BMC BIOTECHNOLOGY
- Purification of mRNA encoding chimeric antigen receptor is critical for generation of robust T cell response
- (2018) Jessica Bobula Foster et al. HUMAN GENE THERAPY
- Rewiring T-cell responses to soluble factors with chimeric antigen receptors
- (2018) ZeNan L Chang et al. Nature Chemical Biology
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
- (2018) Vincent Yi Sheng Oei et al. Cancer Immunology Research
- In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
- (2018) Anett Pfeiffer et al. EMBO Molecular Medicine
- PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
- (2018) Hamideh Parhiz et al. JOURNAL OF CONTROLLED RELEASE
- Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
- (2018) Annika M. Frank et al. Molecular Therapy-Methods & Clinical Development
- Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
- (2017) Leah Alabanza et al. MOLECULAR THERAPY
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
- (2017) Mehdi Arbabi-Ghahroudi Frontiers in Immunology
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Exclusive Transduction of Human CD4+T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
- (2015) Qi Zhou et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy
- (2013) Fatemeh Rahimi Jamnani et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
- (2013) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticulate Nonviral Agent for the Effective Delivery of pDNA and siRNA to Differentiated Cells and Primary Human T Lymphocytes
- (2012) Anja Schallon et al. BIOMACROMOLECULES
- T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
- (2012) Q. Zhou et al. BLOOD
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
- (2010) K. Breckpot et al. JOURNAL OF VIROLOGY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
- (2009) James N. Kochenderfer et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now